
The global market for pharma and biopharma contract manufacturing is expected to reach more than €332.7 billion by 2018, according …

It’s no secret that the pharmaceutical sector has been on a bumpy ride over the last few years.
Drugs produced in offshore manufacturing plants – even those run by US manufacturers – pose a greater quality risk than …
The pharmaceutical contract manufacturing sector looks set for a return to historical growth over the next five years, after a …
Over the past few years, a significant shift has occurred in the depth and type of relations that the pharma …
Japanese company Mitsui & Co has agreed to buy MBS Co, a company set up earlier this month to house …
A small New Zealand company is trying to find European contract manufacturing partners to help it scale up production of …
Lonza has been awarded two contracts for biological drug candidates in quick succession, including a new deal that will make …
Helsinn is on track to complete construction of a new manufacturing plant for cytotoxic active pharmaceutical ingredients in Biasca, Switzerland, …
Japanese photography and imaging company Fujifilm continued its diversification into other sectors with the acquisition of the Merck/MSD Biomanufacturing Network, …
US oncology specialist Dendreon has decided to hire a contract manufacturer for its cell-based cancer therapy Provenge in Europe to …
The Indian bulk drug industry is expected to expand at an annual growth rate of 21% to reach $16.91 billion …
Our round-up of manufacturing updates includes the world’s first dedicated gene therapy facility, hefty fines for a Chinese drugmaker plus …
There are signs that outsourcing in the pharmaceutical sector is staging a comeback after a couple of tough operating years, …
Scottish contract manufacturing company Angel Biotechnology plans to increase its capacity by taking over a mothballed production facility after signing …